"For WHO FC III PAH that is idiopathic, familial, or anorexigen associated, the clinical decision for treatment with a PO-first strategy is associated with a high survival rate when patients are appropriately risk stratified prior to initiation of therapy"
"For WHO FC III PAH that is idiopathic, familial, or anorexigen associated, the clinical decision for treatment with a PO-first strategy is associated with a high survival rate when patients are appropriately risk stratified prior to initiation of therapy"
このブックマークにはスターがありません。
最初のスターをつけてみよう！
DEFINE_ME
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／